Next, we analyzed the expression of ZRF1 mRNA in patients with the most common segmental copy alterations associated with neuroblastoma prognosis, including 1p36 loss of heterozygosity (LOH), unbalanced 11q LOH, and unbalanced 17q gain [20,21]. This evidence concerns the gene DNAJC2 and neuroblastoma.